Neuland Laboratories

Neuland Laboratories Limited, headquartered in Hyderabad, India, is a highly respected, pure-play manufacturer of Active Pharmaceutical Ingredients (APIs) and an advanced provider of Contract Research and Manufacturing Services (CRAMS). Founded in 1984, Neuland has steadily built a reputation as a chemically complex, quality-driven organization that partners with some of the world’s most innovative biopharmaceutical companies.

The company operates state-of-the-art manufacturing facilities and a massive R&D center, all of which are rigorously inspected and approved by leading global regulatory bodies, including the US FDA, EDQM, and PMDA. Neuland’s core strength lies in its ability to handle intricate and challenging chemistry, including complex multi-step synthesis, peptide chemistry, and deuterated molecules. Over the years, they have developed a robust portfolio of over 100 high-quality generic APIs across various therapeutic segments such as psychiatry, cardiology, antiasthmatics, and anti-peptic ulcerants.

However, a significant driver of Neuland’s modern growth is its Custom Manufacturing Solutions (CMS) business. In this vertical, Neuland acts as a critical extension of global biotech and pharma companies’ R&D pipelines, guiding New Chemical Entities (NCEs) from early clinical phases through to commercial launch. Their deep expertise in process engineering, analytical method development, and scalable manufacturing ensures that clients’ molecules are produced efficiently and consistently.

Neuland is also deeply committed to sustainability, integrating green chemistry principles and robust environmental management systems into its daily operations, solidifying its role as a trusted, long-term API partner.